Probiotic & Therapeutic Development Cross-Talk: Defining a Route Forward with Therapeutic & Commercial Potential in Mind
Time: 2:30 pm
day: Conference Day One
Details:
- How to leverage expertise and IP landscape awareness to de-risk drug opportunities at an early stage
- Approach to select probiotic clinical / preclinical research programmes to move into a therapeutic setting, or remain within probiotic
- BioGaia Pharma’s pharma pipeline, and approach to de-risking opportunities for internal or external development
